DMI-Logo
search-iconsearch-icon

Oncology Research Reports & Consulting

Home
>
Reports
>
Pharmaceuticals
>
Oncology
Browse reports
DataM has exclusive market relevance and knowledge catering our services in 60+ industries
SUB CATEGORIES
All PharmaceuticalsCardiovascularCentral Nervous SystemDermatologyEar Nose Throat DisordersGastrointestinalGenitourinary DisordersHematologyHormonal DisordersImmunologyInfectious DiseaseMetabolic DisorderDiabetes CareMouth And Dental DisordersPain ManagementMusculoskeletalNeurologyNon-Malignant DisordersNutritional DisordersOncologyOphthalmologyOther DiseasesAllergyRespiratoryWomen's and Male HealthWound Care TreatmentSyndromeOthers
FILTER
Geography
Publish Date
Themesdown
SORT
Upload Date
Upload Date
Price
Published: 2026 August 14
Peptide Drug Conjugate Market Size, Pipeline, Trends and Forecast to 2035
Peptide Drug Conjugate market to reach US$ 25.90 billion by 2035 from US$ 4.53 billion in 2025, growing at 19.0% CAGR across oncology and genetic diseases.
Starting from
$4350$3480
Published: 2026 July 28
Synthetic Lethality Drugs Market for PARP Inhibitors, ATR, WEE1, USP1, POLQ and Biomarker-Led Oncology 2026-2035
The synthetic lethality drugs market reached US$ 6.42 billion in 2025 and is projected to reach US$ 19.58 billion by 2035, growing at 11.8% CAGR as PARP inhibitors, ATR, WEE1, USP1, POLQ, PRMT5 and biomarker-selected oncology therapies advance.
Starting from
$4350$3480
Published: 2026 July 16
Bispecific Antibodies in Precision Oncology Market Size, Share and Forecast 2033
Bispecific antibodies in precision oncology market reached US$17.95B in 2025 and is projected to reach US$332.77B by 2033, growing at a CAGR of 44.05%.
Starting from
$4350$3480
Published: 2026 July 27
Tumor Microenvironment Targeted Oncology Therapies Market Size, Share and Forecast 2033
Tumor microenvironment targeted oncology therapies market was US$1.92B in 2025 and is projected to reach US$5.11B by 2033, growing at a CAGR of 13%.
Starting from
$4350$3480
Published: 2026 March 26
Pleuropulmonary Blastoma Treatment Market 2033: Global Size, Growth Trends & Diagnostic Advances
The global pleuropulmonary blastoma treatment market size reached US$ 649.44 Million in 2025 and is expected to reach US$ 995.33 Million by 2033
Starting from
$4350$3480
Published: 2025 December 17
Prostate Cancer Drugs Market Size & Forecast 2025–2033: Growth Trends & Leading Therapies
Global prostate cancer drugs market to reach USD 28.10B by 2033 at 8.1% CAGR. Explore therapy trends, key players, and regional growth analysis.
Starting from
$4350$3480
Published: 2026 March 26
Desmoid Tumors Market- Size, Share and Forecast Analysis (2026-2033)
Explore the global Desmoid Tumors Market size, trends, and forecasts to 2033. Learn how Ogsiveo approval, targeted therapy, and R&D are driving growth.
Starting from
$4350$3480
Published: 2026 August 12
Oncology Biosimilars Market Size, Share, Trends, and Forecast (2026-2035)
The Oncology Biosimilars Market is projected to grow from US$ 8.02 billion in 2026 to US$ 50.02 billion by 2035 at a CAGR of 18.6%.
Starting from
$4350$3480
Published: 2025 September 11
Breast Cancer Therapeutics Market Size, Share & Growth Outlook (2024–2033)
The breast cancer therapeutics market reached US$ 37.75 Bn in 2024 and is projected to hit US$ 72.05 Bn by 2033 at a 9.4% CAGR. Explore therapies, key players, and regional insights.
Starting from
$4350$3480
Published: 2026 April 17
Breast Cancer Treatment Market Size, Share Analysis, Growth Trends and Forecast Report 2025-2033
Breast Cancer Treatment Market size reached US$ 37.75 billion in 2024 and is expected to reach US$ 72.05 billion by 2033
Starting from
$4350$3480